本年度信息
根据前海健康控股有限公司公告,集团截至2025年12月31日止年度的非GAAP净利润预计介乎500万港元至600万港元,同比2024年度的约130万港元实现显著提升。公司方面表示,合并净利润增长主要由于在本财年未计提损合约拨备所致。
业务分项
公告暂未披露各业务板块的营收与增幅情况。
本年度信息
根据前海健康控股有限公司公告,集团截至2025年12月31日止年度的非GAAP净利润预计介乎500万港元至600万港元,同比2024年度的约130万港元实现显著提升。公司方面表示,合并净利润增长主要由于在本财年未计提损合约拨备所致。
业务分项
公告暂未披露各业务板块的营收与增幅情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.